In 2025, the largest initial public offering was by Medline, a medical supply company in Chicago. With a history of rapid, profitable sales growth, Medline is set to continue its success. Serving all points of care with 335,000 products in over 100 countries, it’s known as the Amazon of medical supplies. The company had a $6.3 billion IPO, aiming to pay down debt.

Medline has shown strong sales growth, averaging 18% annually since 1966. Analysts project earnings of $1.17 per share for 2025 and $1.52 per share for 2026. The company’s gross, operating, and net margins are significantly higher than key rivals in the industry.

Investors may be concerned about Medline’s high P/E multiple and concentration on hospital sales. However, the company’s growth track record and solid financials make it an attractive investment option.

Read more at Nasdaq: How the Largest IPO of 2025 Could Be Healthy for Your Portfolio